EXHIBIT 23.2

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

We consent to the reference to our firm under the caption "Experts" in the
Registration Statement on Form S-3 and the related Prospectus of Medicis
Pharmaceutical Corporation relating to the registration of $400,000,000 in
aggregate principal amount of its 2.5% Contingent Convertible Senior Notes due
2032 and 6,884,681 shares of its Class A common stock and to the incorporation
by reference therein of our report dated August 8, 2001, with respect to the
consolidated financial statements and schedule of Medicis Pharmaceutical
Corporation included in its Annual Report on Form 10-K for the year ended June
30, 2001, filed with the Securities and Exchange Commission.


                                                           /s/ Ernst & Young LLP

Phoenix, Arizona
July 25, 2002